Peer Review History
| Original SubmissionJuly 4, 2021 |
|---|
|
PONE-D-21-21462Birth-related retinal hemorrhages: The Soonchunhyang University Cheonan Hospital universal newborn eye screening (SUCH-NES) studyPLOS ONE Dear Dr. Kim, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== ACADEMIC EDITOR: The manuscript is well-written and the number of included patients is quite impressive. I would suggest the authors highlight the difference between "clinical significance" and "statistical significance" in their study and discussion. The differences in gestational age and Apgar scores for example while might be statistically significant is too minute to be clinically significant. ============================== Please submit your revised manuscript by Oct 21 2021 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Ahmed Awadein, MD, Ph.D, FRCS Academic Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. We note that you have stated that you will provide repository information for your data at acceptance. Should your manuscript be accepted for publication, we will hold it until you provide the relevant accession numbers or DOIs necessary to access your data. If you wish to make changes to your Data Availability statement, please describe these changes in your cover letter and we will update your Data Availability statement to reflect the information you provide. 3. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. 4. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes Reviewer #3: Yes ********** 5. Review Comments to the Author Please use the space provided to explain your answers to the questions above. You may also include additional comments for the author, including concerns about dual publication, research ethics, or publication ethics. (Please upload your review as an attachment if it exceeds 20,000 characters) Reviewer #1: Great paper. Congratulations. This paper would be very helpful in enhancing our understanding of RH in neonates. I have no concerns regarding ethics on this paper. Well written paper that is easy to understand. Reviewer #2: • This was a prospective, observational study aimed at evaluating the prevalence and clinical factors related to birth-related retinal hemorrhages. The large number of eyes is impressive, and makes up for the relatively short follow-up period. • The authors regularly mention the term "civil clinics" which I am not familiar with, and could not find adequate information on. Please elaborate on what they are and whether they are different from regular clinics. • Methods: o The authors determined a history of systemic illness as an exclusion criterion. Does this include both maternal and fetal illness? Were there records on maternal blood disorders or medications that may influence clotting and predispose to hemorrhages? o The authors do not mention any details on the length and difficulty of the vaginal deliveries. Were there appliances used in any of them? Please elaborate and compare this data to the described ocular findings. o The authors do not mention whether any of the CS deliveries attempted vaginal deliveries first before converting to CS. This may skew the results in the CS group. Please confirm. o The data suggests some of these newborns' APGAR scores were low. Were any of them distressed? Did any require oxygenation, intubation or any other medical procedures that may have contributed to the development of hemorrhages? o The authors mention in page 6, line 121 that eyes with abnormal ocular findings were referred to a pediatric ophthalmologist. Were these eyes removed from the total cohort of eyes? o The authors divided the eyes by severity into 4 groups based on the number of retinal hemorrhages. Please elaborate on the rationale behind the specific thresholds used in this classification. o The authors mention that the images were reviewed by a single grader. Why wasn't a double-grader analysis used? Was the grader masked to the clinical history of the newborns they were assessing? Methodology involving subjective analysis of data usually involves double-grading and blinding to ensure the absence of bias and error. Please explain. o The quality of some of the images used is questionable. One might argue that panel D2 in figure 1 is too hazy to determine the quantify and localize all hemorrhages in this eye. Please expand on this issue. • Results: o P. 7, lines 165-172: these numbers are already mentioned in table 2. There is no need to repeat them. • Tables: o Almost all tables require editing. The numbers and parentheses are not properly spaced. • Minor edits: o P.6, line 115: Add "s" to "hour". Reviewer #3: This is the largest study to date of newborn retinal hemorrhages. The size is impressive. The main conclusion is that 20-25% of healthy newborns have some degree of retinal hemorrhages, the vast majority of which will resolve over then ensuing few weeks. As has been extensively described previously, NSVB is the main risk factor for retinal hemorrhages, theoretically due to compression though this has not been proven. Thus, while the main findings reported in this paper are not novel, they are certainly sound given the astronomical sample size. The authors should be commended for undertaking such a task. My only concern is that some of the other associations reported seem to be so minuscule in terms of the absolute value of the difference that the clinical relevance is questionable. The association to female sex has a clinically irrelevant O.R. and the difference is a single percentage point. The difference in gestational age is less than 2 days. The difference in Apgar score at 1 minute is 0.04! These things are so minuscule that it makes me wonder about the distribution of the data and whether there is some batch effect leading to spurious findings. I would request that the authors provide some additional analysis to investigate possible confounders (perhaps redoing the statistics several times, each time with a single hospital removed) to see if the results are robust. I would also switch to non-parametric testing (e.g. rank-sum for continuous variables). The discussion could benefit from more speculation about why these minuscule differences exist. There should also be more discussion about the full differential for retinal hemorrhages in a newborn beyond cranial compression (i.e. things like Terson's, clotting disorders, etc). In addition (perhaps most importantly), there is NO discussion about non-accidental trauma (and this CAN occur in the hospital). Figure 1-C1, Figure 2-D are very concerning and there should be some acknowledgement of this and discussion about any further exam or inquiry that was done given the appearance of widespread hemorrhage in several layers. ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: Yes: Donny Suh Reviewer #2: No Reviewer #3: No [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Birth-related retinal hemorrhages: The Soonchunhyang University Cheonan Hospital universal newborn eye screening (SUCH-NES) study PONE-D-21-21462R1 Dear Dr. Kim, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Ahmed Awadein, MD, Ph.D, FRCS Academic Editor PLOS ONE Additional Editor Comments (optional): Reviewers' comments: |
| Formally Accepted |
|
PONE-D-21-21462R1 Birth-related retinal hemorrhages: The Soonchunhyang University Cheonan Hospital universal newborn eye screening (SUCH-NES) study Dear Dr. Kim: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Ahmed Awadein Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .